Quantitative control of active targeting of nanocarriers to tumor cells through optimization of folate ligand density

Biomaterials ◽  
2014 ◽  
Vol 35 (27) ◽  
pp. 8015-8027 ◽  
Author(s):  
Zhaomin Tang ◽  
Dan Li ◽  
Huili Sun ◽  
Xing Guo ◽  
Yuping Chen ◽  
...  
2017 ◽  
Vol 23 (3) ◽  
pp. 454-466 ◽  
Author(s):  
Daniele R. Nogueira-Librelotto ◽  
Cristiane F. Codevilla ◽  
Ammad Farooqi ◽  
Clarice M. B. Rolim

A lot of effort has been devoted to achieving active targeting for cancer therapy in order to reach the right cells. Hence, increasingly it is being realized that active-targeted nanocarriers notably reduce off-target effects, mainly because of targeted localization in tumors and active cellular uptake. In this context, by taking advantage of the overexpression of transferrin receptors on the surface of tumor cells, transferrin-conjugated nanodevices have been designed, in hope that the biomarker grafting would help to maximize the therapeutic benefit and to minimize the side effects. Notably, active targeting nanoparticles have shown improved therapeutic performances in different tumor models as compared to their passive targeting counterparts. In this review, current development of nano-based devices conjugated with transferrin for active tumor-targeting drug delivery are highlighted and discussed. The main objective of this review is to provide a summary of the vast types of nanomaterials that have been used to deliver different chemotherapeutics into tumor cells, and to ultimately evaluate the progression on the strategies for cancer therapy in view of the future research.


2016 ◽  
Vol 13 (8) ◽  
pp. 2844-2854 ◽  
Author(s):  
Moraima Morales-Cruz ◽  
Alejandra Cruz-Montañez ◽  
Cindy M. Figueroa ◽  
Tania González-Robles ◽  
Josue Davila ◽  
...  

Biomaterials ◽  
2019 ◽  
Vol 188 ◽  
pp. 130-143 ◽  
Author(s):  
Tongmeng Jiang ◽  
Jinmin Zhao ◽  
Shan Yu ◽  
Zhengwei Mao ◽  
Changyou Gao ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 1185
Author(s):  
Elia Bari ◽  
Massimo Serra ◽  
Mayra Paolillo ◽  
Eric Bernardi ◽  
Sara Tengattini ◽  
...  

Arg-Gly-Asp (RGD)-based cyclopentapeptides (cRGDs) have a high affinity towards integrin αvβ3 and αvβ5, which are overexpressed by many tumor cells. Here, curcumin-loaded silk fibroin nanoparticles (SFNs) have been functionalized on the surface with cRGD to provide active targeting towards tumor cells; a “click reaction” between the RGD-based cyclopentapeptide carrying an azide group and triple-bond-functionalized nanoparticles has been exploited. Both naked and functionalized SFNs were less than 200 nm in diameter and showed a round-shaped morphology but, after functionalization, SFNs increased in size and protein molecular weight. The functionalization of SFNs’ surfaces with cRGD provided active internalization by cells overexpressing integrin receptors. At the lowest concentration tested (0.01 mg/mL), functionalized SFNs showed more effective uptake with respect to the naked by tumor cells that overexpress integrin receptors (but not for non-overexpressing ones). In contrast, at higher concentrations, the non-specific cell membrane protein–particle interactions are promoted and coupled to specific and target mediated uptake. Visual observations by fluorescence microscopy suggested that SFNs bind to integrin receptors on the cell surface and are then internalized by endocytosis. Overall, SFN functionalization provided in vitro active targeting for site-specific delivery of anticancer drugs, boosting activity and sparing healthy organs.


2012 ◽  
Vol 3 (12) ◽  
pp. 1008-1012 ◽  
Author(s):  
Eunhwa Ko ◽  
Anyanee Kamkaew ◽  
Kevin Burgess

2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Silvia Arpicco ◽  
Giuseppe De Rosa ◽  
Elias Fattal

Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan that exists in living systems, and it is a major component of the extracellular matrix. The hyaluronic acid receptor CD44 is found at low levels on the surface of epithelial, haematopoietic, and neuronal cells and is overexpressed in many cancer cells particularly in tumour initiating cells. HA has been therefore used as ligand attached to HA-lipid-based nanovectors for the active targeting of small or large active molecules for the treatment of cancer. This paper describes the different approaches employed for the preparation, characterization, and evaluation of these potent delivery systems.


2014 ◽  
Vol 14 (15) ◽  
pp. 1250-1263 ◽  
Author(s):  
Biswajit Mukherjee ◽  
Bhabani Satapathy ◽  
Laboni Mondal ◽  
Niladri Dey ◽  
Ruma Maji

2020 ◽  
Vol 184 ◽  
pp. 105106 ◽  
Author(s):  
Yan Gao ◽  
Yanbin Shi ◽  
Li Wang ◽  
Shengli Kong ◽  
Jian Du ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document